The FormuTech Summit is a premier gathering for leaders in the pharmaceutical, biotechnology, and academic fields, focused on advancing mRNA process development, manufacturing, and LNP formulations. This event brings together experts to explore critical topics such as accelerating the transition of mRNA technologies from research to commercial scale, mastering the characterization of lipid nanoparticles, and addressing the global challenges in mRNA vaccine manufacturing. The summit also delves into the expanding applications of LNPs in gene editing and CRISPR technologies, while envisioning an optimized CMC roadmap for mRNA therapeutics, all within the framework of navigating complex technical and regulatory landscapes to ensure compliance, safety, and efficacy.
With over 80 senior industry experts in attendance, the FormuTech Summit fosters a hub of knowledge exchange and collaboration. Attendees engage in insightful discussions, share cutting-edge strategies, and shape the future of advanced therapeutics. The event offers unparalleled opportunities for networking, connecting over 100 professionals from various sectors to spark new ideas, foster partnerships, and propel innovative projects forward.
In addition to enriching presentations and discussions, the FormuTech Summit features carefully curated networking opportunities, including cocktail receptions, speed networking sessions, sponsor presentations, business lunches, and a memorable Gala Dinner. Panel discussions led by industry experts provide diverse perspectives, further enhancing the experience and empowering participants to make informed decisions in the evolving field of mRNA process development and LNP formulations.
Over 20+ Sessions , several networking opportunities in a special venue chosen by our team makes this event unique and unforgettable
1. Empowering mRNA Advancements
Accelerate the journey of mRNA processes from research to commercial scale, ensuring heightened efficiency, stability, and therapeutic relevance to meet stringent regulatory and market demands.
2. Mastering LNP Characterization
Navigate the intricate landscape of Lipid Nanoparticles, unraveling their pharmacokinetic-pharmacodynamic profiles, biodistribution patterns, and re-dosing considerations for enhanced therapeutic efficacy and safety.
3. Global mRNA Manufacturing Challenges
Gain valuable insights into overcoming hurdles and bottlenecks faced in the worldwide manufacturing of mRNA vaccines, forging a path toward a more resilient and responsive production landscape.
4. Expanding LNP Applications
Harness the power of LNPs for gene editing, RNA and DNA applications, as well as CRISPR technologies. Explore strategies to encapsulate intricate payloads, including oligonucleotides, for unparalleled therapeutic potential.
5. Envisioning an Optimized CMC Roadmap
Chart the course toward an advanced Chemistry, Manufacturing, and Controls (CMC) strategy for the production of mRNA therapeutics, empowering a future of consistent quality and long-term efficacy.
6. Navigating Technical and Regulatory Landscapes
Overcome technical and regulatory hurdles inherent in the development and manufacturing of mRNA vaccines, ensuring compliance, safety, and efficacy.
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments of:
20-21 November, 2025 | New York, USA
© 2017 Copyright All Rights Reserved | Powered by EPM Group